Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
FDA review challenges Amgen on a questionable T-Vec study
Fierce Biotech
Mon, 04/27/15 - 09:46 am
FDA
Amgen
T-Vec
Talimogene Laherparepvec
cancer
cancer vaccines
ThromboGenics spins out Roche-rejected cancer drug
Fierce Biotech
Thu, 04/16/15 - 09:59 am
ThromboGenics
Roche
TB-403
cancer
A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs. Reality
Forbes
Wed, 04/8/15 - 11:02 am
cancer
Oncolytics
Brad Thompson
New cancer drugs "vastly overestimated", says contrarian analyst
Yahoo/Reuters
Tue, 03/31/15 - 12:46 pm
cancer
PD-1 inhibitors
PDL-1 inhibitors
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Investors Bet $100,000 Cancer Drug Prices Are Here to Stay
Bloomberg
Mon, 03/9/15 - 12:26 pm
drug pricing
cancer
Keytruda
Opdivo
Imbruvica
Global cancer drug market to grow to $111 billion by 2020: report
Medical Marketing and Media
Tue, 02/24/15 - 05:02 pm
cancer
cancer immunotherapy
Merck
Bristol-Myers Squibb
PD-1 inhibitors
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Novartis
GSK
cancer
BRAF inhibitor
MEK inhibitor
Is Revlimid Becoming a Catch-All Cancer Drug?
24/7 Wall St
Thu, 02/19/15 - 07:54 am
Revlimid
Celgene
Multiple Myeloma
cancer
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics
Array shares jump after drugmaker details Novartis deal
Yahoo/AP
Fri, 01/23/15 - 03:27 pm
Array Biopharma
Novartis
encorafenib
binimetinib
cancer
Express Scripts Targets $150,000 Cancer Drug Prices in 2016 Plan
Bloomberg
Thu, 01/22/15 - 03:53 pm
cancer
Express Scripts
hepatitis C
The CAR-T brain war: Scientific trailblazer inspires a $45M biotech startup
Fierce Biotech
Thu, 01/22/15 - 09:49 am
CAR-T
biotech
Autolus
cancer
R&D
FDA removes partial clinical hold on CytRx's aldoxorubicin clinical trials
News-medical.net
Tue, 01/20/15 - 09:23 am
FDA
CytRx
aldoxorubicin
cancer
TapImmune offering would help take cancer vaccines to next clinical trials
Bizjournals.com
Tue, 01/13/15 - 08:55 am
TapImmune
vaccines
cancer
After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks
TheStreet.com
Tue, 01/6/15 - 08:56 am
CAR-T
cancer
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
Cancer-fighting CytomX lands $20 million Pfizer investment, makes key hires
Bizjournals.com
Tue, 01/6/15 - 08:53 am
CytomX
Pfizer
cancer
probodies
Big pharma waits decision on cancer drugs
FT.com
Sun, 01/4/15 - 10:26 pm
cancer
Roche
JNJ
Novartis
Merck beefs up its cancer drug pipeline in $375M OncoEthix buyout
Fierce Biotech
Thu, 12/18/14 - 10:04 am
Merck
OncoEthix
M&A
cancer
Gilead Sciences: What Its New Hire Means for Its Cancer Pipeline
Barron's
Mon, 12/15/14 - 03:29 pm
Gilead Sciences
cancer
R&D
oncology
New Cancer Treatments Represent Major Breakthroughs -- But Who Is Going To Pay For Them?
Forbes
Fri, 12/5/14 - 11:02 am
cancer
R&D
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »